top of page
logo rebracovid2.png

Estudo multicêntrico da história natural do novo Coronavírus SARS-CoV-2 no Brasil


A Rebracovid é o primeiro estudo ancilar (complementar) da Replick.



- Caracterizar clinicamente a infecção por SARS-CoV-2;

- Descrever a história natural da doença;

- Avaliar possíveis sequelas pós-infecção.

Translational Research

The research will also perform laboratory analyses to better understand the immune and inflammatory response to the disease and search for tolls that may predict the risk of an individual developing a severe condition.



Constitution of a study biorepository with biological samples.

- Nasopharyngeal swab
- Serum
- Whole blood
- More


Bio-Manguinhos Rapid Test

Evaluate the performance and applicability of the TR DPP® COVID-19 IGM/IGG rapid test developed by the Immunobiological Technology Institute (Bio-Manguinhos/Fiocruz)



- Age 18 and older
- Outpatient or hospitalized patients
- Respiratory illness and/or symptoms of fever (<7 days)
- Household contacts
- Availability to do follow-up visits (up to 1 year)

bottom of page